相关实验视频

Updated: May 6, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

提高对青光眼进展的检测:24-2视野中心点对10-2视野中心点的实用性

Maryam Ashrafkhorasani¹, Sajad Besharati¹, Vahid Mohammadzadeh²

¹Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Ophthalmology. Glaucoma

|November 14, 2024

概括

12点的平均偏差指数 (MD12) 不能取代10-2视野 (VF) 监测中部玻璃眼损伤. MD12显示了与10-2 VF检测率的有限一致性,表明其不适合此目的.

科学领域:

眼科医生眼科眼科
玻璃眼研究研究玻璃眼研究
视觉现场测试视觉现场测试

背景情况:

青光眼的管理依赖于准确的视野 (VF) 测试来检测进展.
24-2 VF是标准的,但中央视力至关重要,可能需要更详细的评估.
从中央24-2VF中导出的12点平均偏差 (MD12) 指数作为潜在的补充度量被调查.

研究的目的:

评估MD12指数是否提供超出标准24-2 VF平均偏差 (MD) 的额外信息.
评估MD12在检测青光眼的进展,特别是在中央视野中的有用性.

主要方法:

一项纵向观察性研究包括了中度至重度绿眼患者的125只眼睛.
分析了瑞典交互值算法 (SITA) 标准的10-2和24-2 VF.
MD12从24-2 VF的12个中心点计算出来. 对24-2MD,10-2MD和MD12的变化率 (RoC) 估计使用线性回归.

主要成果:

基线24-2MD和10-2MD分别为-9.0 ± 6.2dB和-8.5 ± 5.4dB.
MD12与24-2 MD (r=0.84) 和10-2 MD (r=0.86) 显示出强烈的基线相关性.
进展检测率为23.2% (24-2MD),17.6% (10-2MD) 和18.4% (MD12). 病情进展检测率为23.2% (24-2MD),17.6% (10-2MD) 和18.4% (MD12). 病情进展检测率为23.2% (24-2MD),17.6% (10-2MD) 和18.4% (MD12). 病情进展检测率为23.2% (24-2MD),17.6% (10-2MD) 和18.4% (MD12). MD12确定了7只眼睛 (9.6%),在24-2MD中没有出现进展,但在10-2MD中只有3个进展.

结论:

MD12指数及其检测率与10-2 VF的差异一致.
MD12不能替代10-2 VF监测中枢视野损伤在绿眼病.
10-2 VF对于评估中部玻璃眼损伤仍然至关重要.

关键词:

10-2 视野中的视野.24-2-2是什么意思? 24-2是什么意思?眼光障碍眼光障碍眼光障碍眼光障碍这是一个渐进式的进步.汇总指数汇总指数

更多相关视频

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Assessing Binocular Central Visual Field and Binocular Eye Movements in a Dichoptic Viewing Condition

Published on: July 21, 2020

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

相关概念视频

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...